InsidersTradesSigma
Track the PuraPharm Corporation Ltd. stock price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Operating in the Health Care sector, PuraPharm Corporation Ltd. has logged 1 insider filings. Market capitalisation: €152.5m. The latest transaction was filed on 11 May 2026 (Other). Among the most active insiders: Ng Wang Wai Charles. Every trade is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
3Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,700 of 29,064 companies
34.8
score / 100
Value44
Quality26
FCF yld17%
Earn yld-24%
EV/EBITDA16.2x
ROE-24%
Gross mgn54%
Net mgn-10%
Debt/EBITDA11.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 May 2026
Declarations1 total
110,500 sharesShareXHKGHKEX:DA20260508E00567
1 of 1 declaration
关于 PuraPharm Corporation Ltd.
PuraPharm Corporation Ltd.是一家专注于健康和制药领域的公司，提供与中药相关的产品和服务。该公司在香港证券交易所（XHKG）上市。